ZA954947B - Novel substituted alkyldiamine derivatives - Google Patents

Novel substituted alkyldiamine derivatives

Info

Publication number
ZA954947B
ZA954947B ZA954947A ZA954947A ZA954947B ZA 954947 B ZA954947 B ZA 954947B ZA 954947 A ZA954947 A ZA 954947A ZA 954947 A ZA954947 A ZA 954947A ZA 954947 B ZA954947 B ZA 954947B
Authority
ZA
South Africa
Prior art keywords
novel substituted
substituted alkyldiamine
derivatives
alkyldiamine derivatives
useful
Prior art date
Application number
ZA954947A
Other languages
English (en)
Inventor
Timothy Paul Burkholder
Elizabeth Mary Kudlacz
Tieu-Binh Le
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA954947B publication Critical patent/ZA954947B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the nitrogen atom of at least one of the carboxamide groups further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
ZA954947A 1994-06-20 1995-06-14 Novel substituted alkyldiamine derivatives ZA954947B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/262,209 US5597845A (en) 1994-06-20 1994-06-20 Substituted alkyldiamine derivatives

Publications (1)

Publication Number Publication Date
ZA954947B true ZA954947B (en) 1996-01-31

Family

ID=22996631

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA954947A ZA954947B (en) 1994-06-20 1995-06-14 Novel substituted alkyldiamine derivatives

Country Status (20)

Country Link
US (1) US5597845A (enExample)
EP (1) EP0767783B1 (enExample)
JP (1) JP3920916B2 (enExample)
KR (1) KR100371981B1 (enExample)
CN (1) CN1083429C (enExample)
AT (1) ATE169905T1 (enExample)
AU (1) AU691619B2 (enExample)
CA (1) CA2193348C (enExample)
DE (1) DE69504198T2 (enExample)
DK (1) DK0767783T3 (enExample)
ES (1) ES2121389T3 (enExample)
FI (1) FI115135B (enExample)
HU (1) HUT75965A (enExample)
IL (1) IL114185A (enExample)
MX (1) MX9606654A (enExample)
NO (1) NO307458B1 (enExample)
NZ (1) NZ287291A (enExample)
TW (1) TW442451B (enExample)
WO (1) WO1995035279A1 (enExample)
ZA (1) ZA954947B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW541295B (en) * 1999-01-05 2003-07-11 Nippon Zoki Pharmaceutical Co A novel substituted alkylteraamine derivative for use as tachykinin antagonist
US6613801B2 (en) 2000-05-30 2003-09-02 Transtech Pharma, Inc. Method for the synthesis of compounds of formula I and their uses thereof
WO2002070473A2 (en) 2001-03-05 2002-09-12 Transtech Pharma, Inc. Carboxamide derivatives as therapeutic agents
JP2004523565A (ja) 2001-03-05 2004-08-05 トランス　テック　ファーマ，インコーポレイテッド 治療因子としてのベンゾイミダゾール誘導体
EP1482931B1 (en) 2002-03-05 2011-10-19 TransTech Pharma, Inc. Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
US20090263370A1 (en) * 2006-11-30 2009-10-22 Guoliang Tao Methods for treating tachykinin-mediated diseases with cholinesterase
CA2772797C (en) 2009-09-30 2018-09-25 Transtech Pharma, Inc. Substituted imidazole derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164372A (en) * 1989-04-28 1992-11-17 Fujisawa Pharmaceutical Company, Ltd. Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same
WO1993001169A2 (en) * 1991-07-05 1993-01-21 Merck Sharp & Dohme Limited Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
EP1000930A3 (en) * 1992-08-13 2003-10-29 Warner-Lambert Company Tachykinin antagonists

Also Published As

Publication number Publication date
NO965469L (no) 1997-02-19
NZ287291A (en) 1998-10-28
NO965469D0 (no) 1996-12-19
IL114185A0 (enExample) 1995-10-31
HUT75965A (en) 1997-05-28
FI965097L (fi) 1996-12-18
FI115135B (fi) 2005-03-15
JPH10501551A (ja) 1998-02-10
CN1083429C (zh) 2002-04-24
FI965097A0 (fi) 1996-12-18
DK0767783T3 (da) 1999-05-25
KR100371981B1 (ko) 2003-06-12
CN1155883A (zh) 1997-07-30
EP0767783B1 (en) 1998-08-19
EP0767783A1 (en) 1997-04-16
ATE169905T1 (de) 1998-09-15
HU9603540D0 (en) 1997-02-28
AU2596195A (en) 1996-01-15
ES2121389T3 (es) 1998-11-16
AU691619B2 (en) 1998-05-21
TW442451B (en) 2001-06-23
JP3920916B2 (ja) 2007-05-30
DE69504198D1 (de) 1998-09-24
MX9606654A (es) 1997-12-31
US5597845A (en) 1997-01-28
NO307458B1 (no) 2000-04-10
IL114185A (en) 1999-07-14
DE69504198T2 (de) 1999-04-29
CA2193348C (en) 1999-08-24
WO1995035279A1 (en) 1995-12-28
CA2193348A1 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
MX9707879A (es) Derivados de piperazina sustituidos novedosos que tienen actividad antagonista de receptor de taquinina.
PL325339A1 (en) Derivatives of piperasine as neurokinin antagonists
MY132529A (en) Paroxetine hydrochloride anhydrate
MY106280A (en) Novel benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use.
IL128691A0 (en) Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
ZA971183B (en) Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants.
GB0015981D0 (en) Novel process for preparing crystalline particles
BG102589A (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykin antagonists
AU4080097A (en) Piperazino derivatives as neurokinin antagonists
MX9708416A (es) Derivados de piperazino como antagonistas de neuroquininas.
IL114185A0 (enExample)
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
CA2269128A1 (en) Piperazino derivatives as neurokinin antagonists
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
CA2275602A1 (en) Novel carboxy substituted cyclic carboxamide derivatives
CA2215333A1 (en) Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists
CA2275527A1 (en) Novel heterocyclic substituted pyrrolidine amide derivatives
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
TW340108B (en) 1,1-difluoro-1,4-dichlorobutane and process for its preparation
CA2329075A1 (en) Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
IT1256925B (it) Impiego di frammenti o/e di derivati della timosina alfa 1.